Uniwersytecki Dzieciecy Szpital Kliniczny Im. L. Zamenhofa W Bialymstoku — Clinical Trial Site

24 Registered trials

15 Currently recruiting

Organisation

Uniwersytecki Dzieciecy Szpital Kliniczny Im. L. Zamenhofa W Bialymstoku

Location

Bialystok, Poland

Identifier

ORG-100046335

Address

Ul. Jerzego Waszyngtona 17, 15-274, Poland

Departments

048003: Klinika Pediatrii, Gastroenterologii, Hepatologii, Zywienia, Alergologii i Pulmonologii
3502: Klinika Pediatrii, Reumatologii, Immunologii i Chorób Metabolicznych Kości
Clinic Pediatrics, Oncology and Hematology University
Department of Pediatrics, Oncology and Hematology
Klinika Onkologii i Hematologii Dzieciecej
Klinika Pediatrii i Nefrologii
Klinika Pediatrii, Endokrynologii, Diabetologii z Pododdzialem Kardiologii
Klinika Pediatrii, Endokrynologii, Diabetologii z Pododdzialem Kardiologii UMB
Klinika Pediatrii, Endokrynologii, Diabetologii z Pododdziałem Kardiologii
Klinika Pediatrii, Endokrynologii,Diabetologii z Pododdzialem Kardiologii
Klinika Pediatrii, Endokrynologii,Diabetologii z Pododdzialem Kardiologii , ul. J. Waszyngtona 17
Klinika Pediatrii, Onkologii i Hematologii
NA
Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhifa, Klinika Pediatri, Onkologii i Hematologi

Clinical trials at this site (24)

Search interface

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr… Not authorised

2025-523820-26-00 Growth Hormone Deficiency (GHD) 5
Evaluation of the efficacy and safety of prolonged-release budesonide in children with primary IgA nephropathy. Pending

2024-518759-45-00 Children primary nephropathy IgA 5
A Study in Pediatric Participants with Congenital Adrenal Hyperplasia Recruiting

2024-519578-38-00 Classic congenital adrenal hyperplasia 10 2026-03-30
A Phase 3b Multicenter Open-label Trial of the Safety, Tolerability, and Efficacy of Tolvaptan in Infants and Children 28 days to less than … Recruiting

2023-508218-41-00 Autosomal Recessive Polycystic Kidney Disease 5 2023-08-17
Open-label, long-term safety, efficacy, and pharmacokinetics study of vibegron in pediatric subjects 2 years to < 18 years of age with NDO a… Recruiting

2024-513995-16-00 Neurogenic Detrusor Overactivity (NDO) 10 2023-07-28
Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Acute lymphoblastic leukemia 5 2022-12-15
A study to test how well PLENVU®, a bowel cleansing medicine, works in children and teenagers before they have a colonoscopy exam Recruiting

2025-522046-42-00 Colonic disease 5 2026-03-24
A study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diab… Recruiting

2024-519494-19-00 Nutritional and metabolic diseases 5 2025-12-22
An open-label, pharmacokinetic, safety, and efficacy study (Part I, single cycle) and double-blind, efficacy, non inferiority, and safety st… Recruiting

2024-514321-39-00 Chemotherapy-induced nausea and vomiting 10 2025-05-06
Study to evaluate efficacy and safety of inclisiran in children aged 6 to under 12 years of age with heterozygous familial hypercholesterole… Recruiting

2024-514594-21-00 Heterozygous Familial Hypercholesterolemia 5 2025-03-13
A multicenter, randomized, blinded, placebo controlled, phase II study to evaluate the safety and efficacy of cell therapy based with artifi… Recruiting

2023-505226-33-00 Presymptomatic diabetes type 1 (stage 1) 4 2025-01-28
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting

2024-518316-39-00 Acute lymphoblastic leukemia 10 2024-11-18
Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy… Recruiting

2022-500531-36-00 Type 1 diabetes mellitus 4 2024-02-02
An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children with Idiopathic Growth Hormone Deficiency Recruiting

2023-504020-25-00 Idiopathic Growth Hormone Deficiency 4 2023-12-28
A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece… Recruiting

2023-504885-50-00 Treatment of children with chronic kidney disease and p 5 2022-11-07
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28
A study to learn how well finerenone works; how safe it is; how it moves into, through, and out of the body; and the effects it has on the b… Ended

2023-504884-17-00 Proteinuria 5 2022-02-04
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Acute lymphoblastic leukemia 5 2021-07-01
Research study to evaluate the experimental drug ferumoxytol, to see how well it works for children with chronic kidney disease (CKD) and ir… Ended

2024-516263-92-00 Iron Deficiency Anemia (IDA) in Pediatric Subjects with 5 2018-06-25
Phase 3, Placebo-Controlled, Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Trial of a 6-Valent OspA-Based Lyme Disease… Ended

2023-509105-72-00 Active immunization against Lyme disease 5 2022-08-10
A clinical study to investigate if the investigational drug Diamyd is safe and can preserve insulin production and secretion in adolescents … Ended

2024-513304-33-00 Type 1 diabetes mellitus 5 2022-03-17
A Phase 3b Multicenter Open-label Trial of the Safety, Tolerability, and Efficacy of Tolvaptan in Infants and Children 28 days to less than … Ended

2023-508217-17-00 Autosomal Recessive Polycystic Kidney Disease 5